AtriCure Tests New Hybrid AF Procedure, Eyes Pivotal Trial
This article was originally published in The Gray Sheet
Executive Summary
AtriCure anticipates completing enrollment within the next few months in a feasibility trial to evaluate a novel hybrid procedure to treat persistent atrial fibrillation, with hopes to launch a pivotal trial next year.